Biblio
Export 1398 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is P [Clear All Filters]
“The Societal Cost of Dementia in Singapore: Results from the WiSE Study.”, J Alzheimers Dis, vol. 51, no. 2, pp. 439-49, 2016.
, “The Societal Cost of Dementia in Singapore: Results from the WiSE Study.”, J Alzheimers Dis, vol. 51, no. 2, pp. 439-49, 2016.
, “The Societal Cost of Dementia in Singapore: Results from the WiSE Study.”, J Alzheimers Dis, vol. 51, no. 2, pp. 439-49, 2016.
, “Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 69-79, 2016.
, “Specific Binding of Cu(II) Ions to Amyloid-Beta Peptides Bound to Aggregation-Inhibiting Molecules or SDS Micelles Creates Complexes that Generate Radical Oxygen Species.”, J Alzheimers Dis, vol. 54, no. 3, pp. 971-982, 2016.
, “Specific Triazine Herbicides Induce Amyloid-β42 Production.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1593-1605, 2016.
, “Specific Triazine Herbicides Induce Amyloid-β42 Production.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1593-1605, 2016.
, “Specific Triazine Herbicides Induce Amyloid-β42 Production.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1593-1605, 2016.
, “Stability of Progranulin Under Pre-Analytical Conditions in Serum and Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 53, no. 1, pp. 107-16, 2016.
, “Standardized Uptake Value Ratio-Independent Evaluation of Brain Amyloidosis.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1437-1457, 2016.
, “Stimulating the Activity of Amyloid-Beta Degrading Enzymes: A Novel Approach for the Therapeutic Manipulation of Amyloid-Beta Levels.”, J Alzheimers Dis, vol. 54, no. 3, pp. 891-895, 2016.
, “Strategies for improving memory: a randomized trial of memory groups for older people, including those with mild cognitive impairment.”, J Alzheimers Dis, vol. 49, no. 1, pp. 31-43, 2016.
, “Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 271-6, 2016.
, “Three-Dimensional Eigenbrain for the Detection of Subjects and Brain Regions Related with Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1163-79, 2016.
, “Time Orientation and 10 Years Risk of Dementia in Elderly Adults: The Three-City Study.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1411-8, 2016.
, “Time Orientation and 10 Years Risk of Dementia in Elderly Adults: The Three-City Study.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1411-8, 2016.
, “Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges.”, J Alzheimers Dis, vol. 49, no. 3, pp. 617-31, 2016.
, “Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.”, J Alzheimers Dis, vol. 54, no. 2, pp. 559-68, 2016.
, “Transcriptional Analysis of Blood Lymphocytes and Skin Fibroblasts, Keratinocytes, and Endothelial Cells as a Potential Biomarker for Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1373-1383, 2016.
, “Transcriptional Analysis of Blood Lymphocytes and Skin Fibroblasts, Keratinocytes, and Endothelial Cells as a Potential Biomarker for Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1373-1383, 2016.
, “Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.
, “Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.
, “Uncovering the Neural Bases of Cognitive and Affective Empathy Deficits in Alzheimer's Disease and the Behavioral-Variant of Frontotemporal Dementia.”, J Alzheimers Dis, vol. 53, no. 3, pp. 801-16, 2016.
, “Unstable Body Mass Index and Progression to Probable Alzheimer's Disease Dementia in Patients with Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 49, no. 2, pp. 483-91, 2016.
, “Upregulation of Connexin 43 Expression Via C-Jun N-Terminal Kinase Signaling in Prion Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1005-19, 2016.
,